Related references
Note: Only part of the references are listed.Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study
Andrew M. Glazer et al.
CIRCULATION (2022)
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem
Harry P. Selker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients
Hasan Cagin Lenk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Ratios of Acetaminophen Metabolites Identify New Loci of Pharmacogenetic Relevance in a Genome-Wide Association Study
Gaurav Thareja et al.
METABOLITES (2022)
PacBio long-read amplicon sequencing enables scalable high-resolution population allele typing of the complex CYP2D6 locus
Sarah Charnaud et al.
COMMUNICATIONS BIOLOGY (2022)
A comparison on predicting functional impact of genomic variants
Dong Wang et al.
NAR GENOMICS AND BIOINFORMATICS (2022)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2C9andHLA-BGenotypes and Phenytoin Dosing: 2020 Update
Jason H. Karnes et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
Roddy Walsh et al.
GENETICS IN MEDICINE (2021)
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Kristine R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Inferring Protein Sequence-Function Relationships with Large-Scale Positive-Unlabeled Learning
Hyebin Song et al.
CELL SYSTEMS (2021)
SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function
Lingxin Zhang et al.
DRUG METABOLISM AND DISPOSITION (2021)
Disease variant prediction with deep generative models of evolutionary data
Jonathan Frazer et al.
NATURE (2021)
Neural networks to learn protein sequence-function relationships from deep mutational scanning data
Sam Gelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability
Yitian Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram
Line Skute Braten et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Massively parallel characterization of CYP2C9 variant enzyme activity and abundance
Clara J. Amorosi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Next Generation Protein Structure Predictions and Genetic Variant Interpretation
Gaurav D. Diwan et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Quanli Wang et al.
NATURE (2021)
The ethnogeographic variability of genetic factors underlying G6PD deficiency
Maria Koromina et al.
PHARMACOLOGICAL RESEARCH (2021)
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
Maaike van der Lee et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine
Yitian Zhou et al.
SCIENCE ADVANCES (2021)
A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants
Maria-Theodora Pandi et al.
HUMAN GENOMICS (2021)
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Katharina Schwarze et al.
GENETICS IN MEDICINE (2020)
The future of cystic fibrosis care: a global perspective
Scott C. Bell et al.
LANCET RESPIRATORY MEDICINE (2020)
Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
Ye Zhu et al.
GENETICS IN MEDICINE (2020)
Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
Rawan Shekhani et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
CYP2C9andCYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants
Lingxin Zhang et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Phenome-based approach identifies RIC1-linked Mendelian syndrome through zebrafish models, biobank associations and clinical studies
Gokhan Unlu et al.
NATURE MEDICINE (2020)
Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity
Chase C. Suiter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation
Volker M. Lauschke et al.
NPJ GENOMIC MEDICINE (2020)
Ethnogeographic and inter-individual variability of human ABC transporters
Qingyang Xiao et al.
HUMAN GENETICS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits
Robert Lovsletten Smith et al.
TRANSLATIONAL PSYCHIATRY (2020)
Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier
Yitian Zhou et al.
BRITISH JOURNAL OF CANCER (2020)
Long-read human genome sequencing and its applications
Glennis A. Logsdon et al.
NATURE REVIEWS GENETICS (2020)
Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact
Melissa A. Chiasson et al.
ELIFE (2020)
Transfer learning enables prediction of CYP2D6 haplotype function
Gregory McInnes et al.
PLOS COMPUTATIONAL BIOLOGY (2020)
Opportunities and challenges in long-read sequencing data analysis
Shanika L. Amarasinghe et al.
GENOME BIOLOGY (2020)
An optimized prediction framework to assess the functional impact of pharmacogenetic variants
Yitian Zhou et al.
PHARMACOGENOMICS JOURNAL (2019)
Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing
Volker M. Lauschke et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
Gitte Berkers et al.
CELL REPORTS (2019)
Massively Parallel Assays and Quantitative Sequence–Function Relationships
Justin B. Kinney et al.
Annual Review of Genomics and Human Genetics (2019)
Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication
Arjun P. Athreya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Machine Learning in Medicine
Alvin Rajkomar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Applying Multiplex Assays to Understand Variation in Pharmacogenes
Melissa Chiasson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
High-throughput identification of human SNPs affecting regulatory element activity
Joris van Arensbergen et al.
NATURE GENETICS (2019)
Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications
Yusmiati Liau et al.
PHARMACOGENOMICS (2019)
The genetic landscape of the human solute carrier (SLC) transporter superfamily
Lena Schaller et al.
HUMAN GENETICS (2019)
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records
Tonis Tasa et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2019)
A primer on deep learning in genomics
James Zou et al.
NATURE GENETICS (2019)
Genetic variability and population diversity of the human SLCO (OATP) transporter family
Boyao Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Marin M. Jukic et al.
LANCET PSYCHIATRY (2019)
The global spectrum of protein-coding pharmacogenomic diversity
G. E. B. Wright et al.
PHARMACOGENOMICS JOURNAL (2018)
Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants
Andrew S. Tseng et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase
Shikshya Shrestha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Multiplex assessment of protein variant abundance by massively parallel sequencing
Kenneth A. Matreyek et al.
NATURE GENETICS (2018)
From hype to reality: data science enabling personalized medicine
Holger Froehlich et al.
BMC MEDICINE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data
Yitian Zhou et al.
FRONTIERS IN PHARMACOLOGY (2018)
Integrating rare genetic variants into pharmacogenetic drug response predictions
Magnus Ingelman-Sundberg et al.
HUMAN GENOMICS (2018)
Plharmacogenomic Biomarkers for Improved Drug Therapy- Recent Progress and Future Developments
Volker M. Lauschke et al.
AAPS JOURNAL (2018)
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response
Mikael Kozyra et al.
GENETICS IN MEDICINE (2017)
Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
S. Bek et al.
PHARMACOGENOMICS JOURNAL (2017)
Fast and accurate HLA typing from short-read next-generation sequence data with xHLA
Chao Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Genetic variation in human drug-related genes
Charlotta Pauline Irmgard Scharfe et al.
GENOME MEDICINE (2017)
Analysis of population-specific pharmacogenomic variants using next-generation sequencing data
Eunyong Ahn et al.
SCIENTIFIC REPORTS (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors
A. Emami Riedmaier et al.
PHARMACOGENOMICS JOURNAL (2016)
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine
Joshua C. Denny et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 17 (2016)
Genetic Variation Among 82 Pharmacogenes: The PGRNseq Data From the eMERGE Network
W. S. Bush et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records
Sara L. Van Driest et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Heritability of Metoprolol and Torsemide Pharmacokinetics
J. Matthaei et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of Circularity
Dominik G. Grimm et al.
HUMAN MUTATION (2015)
Machine learning applications in genetics and genomics
Maxwell W. Libbrecht et al.
NATURE REVIEWS GENETICS (2015)
Next generation sequencing technology: Advances and applications
H. P. J. Buermans et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
Yuan Ji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Secondary use of clinical data: The Vanderbilt approach
Ioana Danciu et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2014)
Deep mutational scanning: a new style of protein science
Douglas M. Fowler et al.
NATURE METHODS (2014)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Iris Postmus et al.
NATURE COMMUNICATIONS (2014)
Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics
L. M. Yerges-Armstrong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
Matthew R. Nelson et al.
SCIENCE (2012)
HLA DNA Sequence Variation among Human Populations: Molecular Signatures of Demographic and Selective Events
Stephane Buhler et al.
PLOS ONE (2011)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
Pathway-targeted pharmacogenornics of CYP1A2 in human liver
Kathrin Klein et al.
FRONTIERS IN PHARMACOLOGY (2010)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Share Paper
